Dexcom Inc
DXCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001093557
In the last 90 days, Dexcom Inc insiders filed 0 open-market purchases and 12 sales; 976 institutions reported holding it in 13F filings for Q2 2026, worth $26.0B in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Dexcom Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 951 | 13 | 933 | −5 |
| Shares | 358.7M | 8.70M | 364.3M | +14.3M (+4.1%) |
| Value | $27.9B | $676.3M | $24.8B | −$2.40B (−8.8%) |
13 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (110)
Institutions that held Dexcom Inc at the end of Q1 2025 but not at the end of Q4 2024.
Showing the largest 100 of 110 by value.
Sold out (115)
Institutions that held Dexcom Inc at the end of Q4 2024 and filed for Q1 2025 without it.
Showing the largest 100 of 115 by value.
Not filed for Q1 2025 yet (13)
Institutions that held Dexcom Inc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 8,138,522 | $632.9M |
| Caxton Associates LP | 300,000 | $23.3M |
| Swedbank AB | 222,625 | $17.3M |
| Maxwell Wealth Strategies Inc. | 9,097 | $707.5K |
| Wetherby Asset Management Inc | 7,456 | $579.9K |
| Avitas Wealth Management LLC | 6,297 | $489.7K |
| Lake Street Advisors Group, LLC | 4,718 | $366.9K |
| TAP Consulting, LLC | 3,125 | $243.0K |
| Natixis Investment Managers International | 2,883 | $224.2K |
| Global Retirement Partners, LLC | 728 | $56.6K |
| Zions Bancorporation, N.A. | 50 | $3.89K |
| Cassady Schiller Wealth Management, LLC | 28 | $2.18K |
| WR Wealth Planners, LLC | 21 | $1.63K |